Bio-Rad Laboratories, Inc. (BIO)

NYSE: BIO · Real-Time Price · USD

323.00

-0.82 (-0.25%)

At close: Jan 12, 2026, 4:00 PM EST

323.25

+0.25 (0.08%)

After-hours: Jan 12, 2026, 7:28 PM EST

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
United States Revenue	1.04B	1.04B	Log In	Log In	Log In	Upgrade
EMEA Revenue	860.90M	834.10M	Log In	Log In	Log In	Upgrade
APAC Revenue	497.80M	521.60M	Log In	Log In	Log In	Upgrade
Other Regional Revenue	162.00M	169.30M	Log In	Log In	Log In	Upgrade
Revenue (Total)	2.56B	2.57B	Log In	Log In	Log In	Upgrade

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
Life Science Revenue	1.03B	1.03B	Log In	Log In	Log In	Upgrade
Clinical Diagnostics Revenue	1.53B	1.54B	Log In	Log In	Log In	Upgrade
Other Segments Revenue	-	500.00K	Log In	Log In	Log In	Upgrade
Revenue (Total)	2.56B	2.57B	Log In	Log In	Log In	Upgrade

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
Life Science Segment Profit	-	582.40M	Log In	Log In	Log In	Upgrade
Clinical Diagnostics Segment Profit	-	796.60M	Log In	Log In	Log In	Upgrade
Other Segments Segment Profit	-	-100.00K	Log In	Log In	Log In	Upgrade
Gross Profit (Total)	1.34B	1.38B	Log In	Log In	Log In	Upgrade

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
Life Science Operating Profit	-	-	Log In	Log In	Log In	Upgrade
Clinical Diagnostics Operating Profit	-	-	Log In	Log In	Log In	Upgrade
Other Segments Operating Profit	-	-	Log In	Log In	Log In	Upgrade
Operating Income (Total)	224.50M	269.00M	Log In	Log In	Log In	Upgrade

Updated Oct 29, 2025. Data Source: Fiscal.ai.